Development and Enhancement of Liquisolid Compact Containing Rifampicin and Quercetin: An In-Vitro and In-Vivo Investigation
Oluwatoyin A. Adeleke
Abstract
The main objective of this study was to develop liquisolid compacts containing rifampicin and quercetin with enhanced gastrointestinal absorption and dissolution characteristics. To achieve the desired formulations, non-volatile liquid carriers such as propylene glycol, PEG 200, and Tween 20 were selected due to their superior drug solubility properties. The liquisolid formulations were subsequently blended with carrier and coating materials to produce a free-flowing and compressible powder. Avi
Topics & Concepts
In vivoRifampicinIn vitroQuercetinPharmacologyChemistryMedicineBiologyBiotechnologyBiochemistryAntibioticsAntioxidantProteins in Food SystemsPolysaccharides Composition and ApplicationsBotanical Research and Applications